Neuren Pharmaceuticals LimitedASX: NEU

Neuren commences Phase 2 trials of NNZ-2591 in PMS and PTHS

Aug 8, 2022 at 3:34 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment